Product Information
SUBVENITE 25 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0283 per EA under NDC 69102030101. Its NADAC has been published 410 times since Aug 22, 2018.
The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
OWP Pharmaceuticals, Inc.NDC
69102030101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA078947On Market Since
3/10/2018
Pharmacological Classes
Price Statistics
The NADAC for SUBVENITE 25 MG TABLET has been published 410 times since Aug 22, 2018, and over the history we have for it it has declined 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0283 per EA |
|---|---|
| All-time high | $0.0403 (Aug 11, 2021) |
| All-time low | $0.0242 (Nov 20, 2024) |
| 52-week high | $0.0307 |
| 52-week low | $0.0283 |
| Median price | $0.0317 |
| Average price | $0.0323 |
| Largest weekly change | -22.6% (Apr 17, 2024) |
| Weeks tracked | 410 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUBVENITE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUBVENITE 25 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0283 per EA (NDC 69102030101), effective Jun 24, 2026.
How has the price of SUBVENITE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUBVENITE 25 MG TABLET has declined 14.0%. It has been tracked across 410 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for SUBVENITE 25 MG TABLET?
Since Aug 22, 2018, the NADAC for SUBVENITE 25 MG TABLET has ranged from a low of $0.0242 (Nov 20, 2024) to a high of $0.0403 (Aug 11, 2021), with a median of $0.0317 per EA.
Are there cheaper alternatives to SUBVENITE 25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SUBVENITE 25 MG TABLET, but none are currently priced below it.
Who manufactures SUBVENITE 25 MG TABLET?
SUBVENITE 25 MG TABLET (NDC 69102030101) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification